Contagion&reg Editorial Staff

From the London Patient to the DISCOVER trial and everything in between, HIV experts provide their biggest takeaways from CROI 2019.

Bluma Brenner, PhD, confesses that HIV "terrifies the hell" out of her, as it continues to build resistance against existing therapy regimens.

Kristine Erlandson, MD, MS, shares her findings on the connection between obesity and neurocognitive decline in persons with HIV.

Laura Waters, MD, FRCP, an author on the Nature article on the reported HIV remission of the London Patient, explains why it is too soon to label the remission as a cure.

Paul Sax, MD, shares his take on news of the second person ever achieving long-term HIV remission.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Ava Avalos, MD, discusses the "encouraging" 12-month outcomes from the Botswana Beat Cohort study, which employs a dolutegravir-based regimen.

Paul Drain, MD, MPH, discusses the results of a study evaluating point-of-care viral load testing and discusses the advantages to implementation.

Paul Sax, MD, explains how he would demystify PrEP to clinicians who are not comfortable using HIV medications.

W. David Hardy, MD, adjunct professor of medicine in the Division of Infectious Disease at Johns Hopkins University, talks about the challenges of treating patients with HIV and comorbidities.

Paul Sax, MD, explains the lack of concrete progress in the curing of HIV.

We’ve rounded up a list of important US Food and Drug Administration and US Department of Agriculture recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Ian Frank, MD, addresses reasons why some clinicians are not recommending PrEP to individuals who could benefit from the regimen.

The Contagion® editorial staff will be providing exclusive written and video coverage from CROI 2019.

Paul Edward Sax, MD, explains how one obstacle of HIV treatment and care is maintaining adherence.

#ICYMI, here are the highlights from Contagion®'s first-ever TweetChat on Treating Gram-Negative Infections in the Era of Resistance.

W. David Hardy, MD, discusses the Undetectable Equals Untransmittable (U=U) movement.

Ian Frank, MD, discusses the future of HIV prevention and long-acting injectables.

Paul Sax, MD, discusses 2-drug approaches for treatment of HIV, including dolutegravir + lamivudine.

W. David Hardy, MD, discusses how important access to PrEP is for people at high risk of contracting HIV.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Ian Frank, MD discusses how younger individuals who do not take regular medication may struggle to adhere to the daily routine.

Paul Sax, MD, discusses treatments for HIV that are currently in development.

W. David Hardy, MD, discusses the challenges health care providers encounter when it comes to patients taking PrEP.

Ian Frank, MD, discusses strategies that individuals taking PrEP can use to maintain adherence to the daily regimen.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.